The iShares NASDAQ Biotechnology Index (IBB) has been testing the critical 240 level over the last few trading days. If that level does not hold, a hard and fast fall is probably sure to follow. The first key level to target is 225. Chart Credit: Tim Knight Update: June 29, 2016 IBB is testing the…
INO Weekly Chart INO Daily Chart Inovio Pharmaceuticals, Inc. (INO) and GeneOne Life Science, Inc. recently announced that they have received approval to initiate a phase I human trial to evaluate Inovio’s Zika DNA vaccine (GLS-5700) to prevent infection from this concerning virus. In preclinical testing this synthetic vaccine induced robust antibody and T cell responses…
Don’t make it complicated. The Large Cap Pharma Industry is a solid investor niche. Place a few of your stock picking bets here. Here’s the latest top-down data. In mid-June, the 15-company-strong industry has a Zacks Industry Rank of 44 out of 265 (that’s the top 17%). In recent weeks, covering analysts made 10 positive earnings…
MYGN Weekly Chart MYGN Daily Chart Diagnostic giant Myriad Genetics (MYGN) makes the list as one of the cutting-edge healthcare stocks worth stock investor consideration. The idea behind personalized medicine is pretty straightforward: everyone is different, so why should we accept one-size-fits-all medical treatments? Molecular diagnostic companies like Myriad Genetics look for specific genes or biomarkers that…
ANIK Weekly Chart ANIK Daily Chart Anika Therapeutics Inc. (ANIK) continues to evolve. The company’s launch of a new injection, called Cingal, over the next couple years (in various regions of the world) is expected to transform the firm from being a medicines company towards being a biomaterials company. Anika Therapeutics is best known for making so-called viscosupplements –…
The 150 Exponential Moving Average (EMA) has proven to be an identifiable resistance marker for the IBB since the fall of 2015. Mind the blue line. Will the biotech sector lead the major markets down as well? To be continued.
MBRX Weekly Chart MBRX Daily Chart Moleculin Biotech’s common stock began trading earlier this month on the NASDAQ Capital Market under the symbol (MBRX). After pricing at the high end of its range, the stock closed on its first day of trading at $8.00. Net proceeds of that first offering will help finance a Phase II…
GBT Weekly Chart GBT Daily Chart Shares of Global Blood Therapeutics Inc. (GBT) are surging today after claiming its experimental drug (GBT440) boosted hemoglobin production in a small study of patients with sickle cell disease. The study looked at eight patients with sickle cell disease, six of whom took the drug, called GBT440, and two of whom…
IBB Weekly Chart IBB Daily Chart The fall of the biotechnology sector continues today as another important technical resistance point has revealed itself. The RSI for the IBB at 50 on the weekly chart has also provided stout resistance for a year now. Update 6/10/2016 Another classic lesson in buy support and sell resistance.
VBLT Weekly Chart VBLT Daily Chart Shares of Vascular Biogenics (VBLT) are up today by over 70% following positive trial results for the company’s ovarian cancer treatment. The results for the VB-111 drug, which treats patients with recurrent platinum resistant ovarian cancer, were statistically significant. The results demonstrated a median overall survival of 810 days in the…
Drug Stock News 